Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Aldox
2. M-dimethylamine
3. Madp Solution
4. Myristamidopropyl Dimethylamine
1. 45267-19-4
2. N-(3-(dimethylamino)propyl)tetradecanamide
3. Aldox
4. Myristamidopropyl Dimethylamine
5. N-[3-(dimethylamino)propyl]tetradecanamide
6. N-[3-(dimethylamino)propyl]myristamide
7. Schercodine M
8. Dimethylaminopropyl Myristamide
9. N-(3-(dimethylamino)propyl)myristamide
10. Yxs2x34v8w
11. Tetradecanamide, N-(3-(dimethylamino)propyl)-
12. Mfcd02029644
13. Unii-yxs2x34v8w
14. M-dimethylamine
15. Madp Solution
16. Myristic 3-dimethylaminopropylamide
17. Einecs 256-214-1
18. Mapd
19. N,n-dimethyl-(3-tetradecylamidopropyl)amine
20. Schembl94326
21. Dtxsid2068470
22. Schercodine M Amido-amine
23. Stl377897
24. Zinc72399333
25. Akos003262148
26. N-(3-dimethylaminopropyl)tetradecanamide
27. Ac-36417
28. As-63490
29. Sy032069
30. Cs-0152224
31. Ft-0661482
32. Myristamidopropyl Dimethylamine [inci]
33. S10671
34. N,n-dimethyl-n'-tetradecanoyl-1,3-propylenediamine
35. Q27294767
| Molecular Weight | 312.5 g/mol |
|---|---|
| Molecular Formula | C19H40N2O |
| XLogP3 | 6.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 16 |
| Exact Mass | 312.314063904 g/mol |
| Monoisotopic Mass | 312.314063904 g/mol |
| Topological Polar Surface Area | 32.3 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 242 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
Market Place
ABOUT THIS PAGE
77
PharmaCompass offers a list of Myristamidopropyl Dimethylamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Myristamidopropyl Dimethylamine manufacturer or Myristamidopropyl Dimethylamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Myristamidopropyl Dimethylamine manufacturer or Myristamidopropyl Dimethylamine supplier.
PharmaCompass also assists you with knowing the Myristamidopropyl Dimethylamine API Price utilized in the formulation of products. Myristamidopropyl Dimethylamine API Price is not always fixed or binding as the Myristamidopropyl Dimethylamine Price is obtained through a variety of data sources. The Myristamidopropyl Dimethylamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Myristamidopropyl Dimethylamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Myristamidopropyl Dimethylamine, including repackagers and relabelers. The FDA regulates Myristamidopropyl Dimethylamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Myristamidopropyl Dimethylamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Myristamidopropyl Dimethylamine supplier is an individual or a company that provides Myristamidopropyl Dimethylamine active pharmaceutical ingredient (API) or Myristamidopropyl Dimethylamine finished formulations upon request. The Myristamidopropyl Dimethylamine suppliers may include Myristamidopropyl Dimethylamine API manufacturers, exporters, distributors and traders.
Myristamidopropyl Dimethylamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Myristamidopropyl Dimethylamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Myristamidopropyl Dimethylamine GMP manufacturer or Myristamidopropyl Dimethylamine GMP API supplier for your needs.
A Myristamidopropyl Dimethylamine CoA (Certificate of Analysis) is a formal document that attests to Myristamidopropyl Dimethylamine's compliance with Myristamidopropyl Dimethylamine specifications and serves as a tool for batch-level quality control.
Myristamidopropyl Dimethylamine CoA mostly includes findings from lab analyses of a specific batch. For each Myristamidopropyl Dimethylamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Myristamidopropyl Dimethylamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Myristamidopropyl Dimethylamine EP), Myristamidopropyl Dimethylamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Myristamidopropyl Dimethylamine USP).
